Vascular Biology |
From the Department of Cardiovascular Medicine (Y.I., T. Shindo, K.M., M.S., Y.K., H. Morita, Y.O., T. Suzuki, H. Maekawa, R.N.) and the Department of Metabolic Diseases (J.O., S.I., K.T.), Graduate School of Medicine, The University of Tokyo, Tokyo; the 2nd Department of Internal Medicine (Y.S.), School of Medicine, Gunma University, Maebashi; the Department of Geriatric Medicine (M.A.), School of Medicine, Kyorin University, Tokyo; The National Cardiovascular Center Research Institute (K.K., N.M.), Suita; the International Medical Center of Japan (Y.Y.), Tokyo; and the Division of Integrative Cell Biology (H.K.), Department of Embryogenesis, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Correspondence to Hiroki Kurihara, MD, PhD, Division of Integrative Cell Biology, Department of Embryogenesis, Institute of Molecular Embryology and Genetics, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan. E-mail kurihara{at}kaiju.medic.kumamoto-u.ac.jp
Objective Several in vitro studies have implicated that adrenomedullin (AM) plays an important role in the pathogenesis of vascular injury and fatty streak formation. To test this possibility in vivo, we evaluated 2 experimental models using transgenic mice overexpressing AM in a vessel-selective manner (AMTg mice).
Methods and Results Placement of a periarterial cuff on femoral arteries resulted in neointimal formation at 2 to 4 weeks to a lesser extent in AMTg mice than in their wild-type littermates (at 28 days, intima/media area ratio 0.45±0.14 versus 1.31±0.41, respectively; P<0.001). This vasculoprotective effect observed in AMTg mice was inhibited by N
-nitro-L-arginine methyl ester. We further examined the effect of AM on hypercholesterolemia-induced fatty streak formation by crossing AMTg mice with apolipoprotein E knockout mice (ApoEKO mice). The extent of the formation of fatty streak lesions was significantly less in ApoEKO/AMTg mice than in ApoEKO mice (percent lesion area 12.0±3.9% versus 15.8±2.8%, respectively; P<0.05). Moreover, endothelium-dependent vasodilatation as indicative of NO production was superior in AMTg/ApoEKO mice compared with ApoEKO mice.
Conclusions Taken together, our data demonstrated that AM possesses a vasculoprotective effect in vivo, which is at least partially mediated by NO.
Key Words: adrenomedullin transgenic mice neointimal hyperplasia fatty streak apolipoprotein E knockout mice
This article has been cited by other articles:
![]() |
C. Gibbons, R. Dackor, W. Dunworth, K. Fritz-Six, and K. M. Caron Receptor Activity-Modifying Proteins: RAMPing up Adrenomedullin Signaling Mol. Endocrinol., April 1, 2007; 21(4): 783 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Caron, J. Hagaman, T. Nishikimi, H.-S. Kim, and O. Smithies Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males PNAS, February 27, 2007; 104(9): 3420 - 3425. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miyashita, H. Itoh, H. Arai, T. Suganami, N. Sawada, Y. Fukunaga, M. Sone, K. Yamahara, T. Yurugi-Kobayashi, K. Park, et al. The Neuroprotective and Vasculo-Neuro-Regenerative Roles of Adrenomedullin in Ischemic Brain and Its Therapeutic Potential Endocrinology, April 1, 2006; 147(4): 1642 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kato, T. Tsuruda, T. Kita, K. Kitamura, and T. Eto Adrenomedullin: A Protective Factor for Blood Vessels Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2480 - 2487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Ishikawa, K Hatakeyama, T Imamura, K Ito, S Hara, H Date, Y Shibata, Y Hikichi, Y Asada, and T Eto Increased adrenomedullin immunoreactivity and mRNA expression in coronary plaques obtained from patients with unstable angina Heart, October 1, 2004; 90(10): 1206 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamasaki, J. Kawai, T. Nakaoka, T. Ogita, A. Tojo, and T. Fujita Adrenomedullin Overexpression to Inhibit Cuff-Induced Arterial Intimal Formation Hypertension, February 1, 2003; 41(2): 302 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamauchi, J. Kamon, H. Waki, Y. Imai, N. Shimozawa, K. Hioki, S. Uchida, Y. Ito, K. Takakuwa, J. Matsui, et al. Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis J. Biol. Chem., January 17, 2003; 278(4): 2461 - 2468. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |